Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Building wealth without taking high risks is achievable with the right strategies. Explore options that prioritize safety and growth.
27,007 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Memory chips power today’s data centers, AI accelerators, and personal devices. This guide breaks down the case for S...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...
Viral getaway trends can spark inspiration, but they don’t always deliver. This guide breaks down the costs, realitie...
Oracle just delivered a blowout quarterly report, sending the stock higher. This guide breaks down three compelling r...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
A big new stake in Ryan Specialty Holdings hints at growing confidence from a niche investor. This article breaks dow...
Tariffs announced by the administration sparked immediate market volatility and raised red flags for investors. This ...
Fairway Home Mortgage elevates Holly Mattson to co-president of recruiting to accelerate onboarding of loan producers...
Rental-focused development dominated Q4 2025, with 91,000 rental starts among 96,000 total multifamily starts, a jump...
Market fear is loud, but smart investors look for resilient opportunities. Here’s why I’m adding a tech stock to my p...